This is the authors' abstract. We don't add key points for this paper.
Reaction of CuX′2ꞏnH2O (X′ = Br, Cl) with 2-X-3-methylpyridine (X = Br, Cl) in aqueous acid gave (2-chloro-3-methylpyridinium)2[CuCl4] (1), (2-bromo-3-methylpyridinium)2[CuCl4] (2), (2-chloro-3-methylpyridinium)2[CuBr4] (3), (2-bromo-3-methylpyridinium)2[CuBr4] (4), while the reaction of 2-chloro-3-methylpyridinium bromide with CuBr2 in acetonitrile yielded the copper(II) trimer (2-chloro-3-methylpyridinium)2[Cu3Br8] (5). All compounds were characterized by single crystal X-ray diffraction. 1–4 crystalize in the monoclinic space group P21/n with a square planar arrangement of the halide ions about the copper center, which is located on a crystallographic inversion center. 5 crystallizes in the monoclinic space group P21/c and exhibits stacks of Cu3Br82− ions. Variable field and temperature magnetic measurements on 1–4 show modest antiferromagnetic interactions with the tetrabromidocuprates exhibiting stronger interactions. Fits to the uniform magnetic chain model yielded: 1, Curie constant (CC) = 0.438(2) emu-K/mol-Oe, J/kB = −4.63(5) K; 2, CC = 0.431(1) emu-K/mol-Oe, J/kB = −4.53(3) K; 3, CC = 0.415(2) emu-K/mol-Oe, J/kB = −21.6(2) K; 4, CC = 0.408(2) emu-K/mol-Oe, J/kB = −23.9(6) K. A Curie-Weiss correction employed in the fitting shows the chains to be highly magnetically isolated.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Turnbull et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: